
Impact of clinical manifestations of vitiligo on patients’ quality of life of patients
Журнал: Клиническая дерматология и венерология. 2026;25(5):737-744.
DOI: 10.17116/klinderma202625051737
Read: 703 раза
Abstract
Vitiligo is classified as an acquired hypomelanosis with a genetic predisposition to autoimmune reactions. The disease presents with focal depigmentation. Vitiligo is often mistakenly regarded as a cosmetic defect, and proper examination and treatment are neglected. The clinical manifestations of the disease have a significant impact on patients’ quality of life. This article is devoted to a comprehensive analysis of the psychosocial aspects of vitiligo and their impact on patients’ quality of life. In addition to investigating the etiology, pathogenesis, and clinical manifestations of the disease, the psychological status and quality of life of patients are considered in detail. Particular attention is paid to factors determining the degree of quality of life impairment in vitiligo, including gender differences, age, lesion location, and the patient’s socioeconomic status. It has been established that the presence of depigmentation lesions on exposed areas of the body significantly exacerbates the psychological burden of the disease and impedes patients’ social adaptation. The results of large international studies, demonstrating the significant impact of vitiligo on the emotional state and social adaptation of patients, are presented. This article highlights the need for a comprehensive approach to vitiligo management, including not only dermatological but also psychological support. The findings can be used to develop effective treatment and support strategies for patients with vitiligo.
Keywords
- vitiligo
- quality of life
- questionnaire
- hypopigmentation
- psychodermatology
- quality of life assessment
Дата поступления: 24.04.2025
Дата принятия в печать: 16.07.2026
Дата публикации: 10.11.2026
- Koshevenko YuN. Vitiligo. Clinic, etiology, pathogenesis, treatment, rehabilitation, prevention. M.: Medicine; 2002. (In Russ.).
- Taïeb A, Picardo M; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27-35. https://doi.org/10.1111/j.1600-0749.2006.00355.x
- Halder RM, Chappell JL. Vitiligo update. Semin Cutan Med Surg. 2009; 28(2):86-92. https://doi.org/10.1016/j.sder.2009.04.008
- Kruglova LS. Vitiligo: modern views on the etiology and methods of therapy. Russian Journal of Skin and Venereal Diseases. 2016;19(4):241-244. (In Russ.).
- Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020;38:621-648. https://doi.org/10.1146/annurev-immunol-100919-023531
- Silverberg JI, Silverberg NB. Vitiligo disease triggers: psychological stressors preceding the onset of disease. Cutis. 2015;95(5):255-262.
- Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012; 25(3):E1-13. https://doi.org/10.1111/j.1755-148X.2012.00997.x
- Ucuz I, Altunisik N, Sener S, Turkmen D, Kavuran NA, Marsak M, et al. Quality of life, emotion dysregulation, attention deficit and psychiatric comorbidity in children and adolescents with vitiligo. Clin Exp Dermatol. 2020;16:22. https://doi.org/10.1111/ced.14196
- Chen CY, Wang WM, Chung CH, Tsao CH, Chien WC, Hung CT. Increased risk of psychiatric disorders in adult patients with vitiligo: a nationwide, population-based cohort study in Taiwan. J Dermatol. 2020;47:470-475. https://doi.org/10.1111/1346-8138.15290
- Petunina VV, Potekaev NN, Zhukova OV. Research trends in vitiligo development mechanisms and concomitant autoimmune conditions. Russian Journal of Clinical Dermatology and Venereology. 2022;21(3):291-295. (In Russ.). https://doi.org/10.17116/klinderma202221031291
- Chang Y, Zhang S, Zhang W, Li S, Li C. The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment. Front Med (Lausanne). 2022;9:818543. https://doi.org/10.3389/fmed.2022.818543
- Al-Harbi M. Prevalence of depression in vitiligo patients. Skinmed. 2013;11(6):327-330.
- Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1(1):73-77. https://doi.org/10.1016/0163-8343(79)90081-1
- Silverberg JI, Silverberg NB. Association Between Vitiligo Extent and Distribution and Quality-of-Life Impairment. JAMA Dermatol. 2013;149(2): 159-164. https://doi.org/10.1001/jamadermatol.2013.927
- Varzhapetyan AA, Dorozhenok IYu, Lomonosov KM. Vitiligo and comorbid psychosomatic disorders. Russian Journal of Skin and Venereal Diseases. 2019;22(1-2):33-38. (In Russ.).
- Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self‐reported health‐related quality of life. British Journal of Dermatology. 2005;152(6):1165-1172. https://doi.org/10.1111/j.1365-2133.2005.06456.x
- Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58. https://doi.org/10.1186/1477-7525-1-58
- Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Ballanger F, et al. Living with vitiligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173(2):607-609. https://doi.org/10.1111/bjd.13839
- Merhi S, Salameh P, Abboud M, Seneschal J, Eleftheriadou V, Pane I, et al. Facial involvement is reflective of patients’ global perception of vitiligo extent. Br J Dermatol. 2023;189(2):188-194. https://doi.org/10.1093/bjd/ljad109
- Bibeau K, Ezzedine K, Harris JE, et al. Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study. JAMA Dermatol. 2023;159(10):1124-1128. https://doi.org/10.1001/jamadermatol.2023.2787
- Picardo M, Huggins RH, Jones H, Marino R, Ogunsola M, Seneschal J. The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol. 2022;36(9):1507-1523. https://doi.org/10.1111/jdv.18129
- Dertlioğlu SB, Cicek D, Balci DD, Halisdemir N. Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. Int J Dermatol. 2013;52(1):96-101. https://doi.org/10.1111/j.1365-4632.2012.05616.x
- Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11-8. https://doi.org/10.1016/j.jaad.2012.01.038
- Gupta V, Sreenivas V, Mehta M, Ramam M. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2019;180(3):580-585. https://doi.org/10.1111/bjd.17040
- Narayan VS, Uitentuis SE, Luiten RM, Bekkenk MW, Wolkerstorfer A. Patients’ perspective on current treatments and demand for novel treatments in vitiligo. J Eur Acad Dermatol Venereol. 2021;35(3):744-748. https://doi.org/10.1111/jdv.16927
- Taieb A, Alomar A, Böhm M, Dell’anna ML, De Pase A, Eleftheriadou V, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5-19. https://doi.org/10.1111/j.1365-2133.2012.11197.x
- Abdel-Malek ZA, Jordan C, Ho T, Upadhyay PR, Fleischer A, Hamzavi I. The enigma and challenges of vitiligo pathophysiology and treatment. Pigment Cell Melanoma Res. 2020;33:778-787. https://doi.org/10.1111/pcmr.12878
- Passeron T. Medical and Maintenance Treatments for Vitiligo. Dermatol Clin. 2017;35:163-170. https://doi.org/10.1016/j.det.2016.11.007
- Rajatanavin N, Suwanachote S, Kulkollakarn S. Dihydroxyacetone: a safe camouflaging option in vitiligo. Int J Dermatol. 2008;47:402-406. https://doi.org/10.1111/j.1365-4632.2008.03356.x
- Tanioka M, Yamamoto Y, Kato M, Miyachi Y. Camouflage for patients with vitiligo vulgaris improved their quality of life. J Cosmet Dermatol. 2010;9:72-75. https://doi.org/10.1111/j.1473-2165.2010.00479.x
- Bassiouny D, Hegazy R, Esmat S, Gawdat HI, Ahmed Ezzat M, Tawfik HA, et al. Cosmetic camouflage as an adjuvant to vitiligo therapies: effect on quality of life. J Cosmet Dermatol. 2021;20:159-165. https://doi.org/10.1111/jocd.13459
- Rousseau K, Kauser S, Pritchard LE, Warhurst A, Oliver RL, Slominski A, et al. Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis. FASEB J. 2007;21:1844-1856. https://doi.org/10.1096/fj.06-7398com
- Pal SK, Ghosh KK, Panja RK, Banerjee PK. Adrenocortical function in vitiligo. Clin Chim Acta. 1981;113:325-327. https://doi.org/10.1016/0009-8981(81)90286-2
Recommended articles:
Assessment of quality of life as a criterion for the effectiveness of treatment of patients with rosacea (according to two clinical cases).Journal of Adaptive Medical Immunology and Public Health Issues. 2026;2(2-3):72-78
Clinical and laboratory features and quality of life of children with severe bronchial asthma.Journal of Adaptive Medical Immunology and Public Health Issues. 2026;2(2-3):41-48
Complex non-drug therapies in patients with vasovagal syncope, adherence to treatment and quality of life.Russian Cardiology Bulletin. 2026;21(3):74-82
Experience in using a TAP block during TAPP surgery for inguinal hernia in a short-stay hospital setting.Endoscopic Surgery. 2026;32(5):48-54
Evaluation of spike formation and quality of life in patients with primary midline ventral hernias after endoscopic eTEP Sublay and IPOM surgeries: a cohort study.Endoscopic Surgery. 2026;32(5):20-29
Chronic bronchitis in outpatient practice: unsolved diagnostic problems and therapeutic challenges.Russian Journal of Preventive Medicine. 2026;29(9):110-115
Awareness and attitudes of Russian physicians about breast arterial calcification — a new marker of cardiovascular risk in women.Russian Journal of Preventive Medicine. 2026;29(9):7-14
Prevalence of mental disorders and syndromic mental distress in patients with chronic dermatoses: A cross-sectional epidemiological study.S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(7):107-114
Skin hypopigmentation: modern approaches to classification, pathogenesis and differential diagnosis.Russian Journal of Clinical Dermatology and Venereology. 2026;25(3):347-354
Onychomycosis as a sociomedical problem: assessment of patients’ quality of life with the modified OnyCOE-T questionnaire.Russian Journal of Clinical Dermatology and Venereology. 2026;25(1):40-46
